News Releases
 
 
 
News Releases






FOR IMMEDIATE RELEASE

Contact:
Robyn Heine
Dow AgroSciences
PH: 317/337-4807

Sheldon Richardson
W3
PH: 480/222-8510



Dow AgroSciences, World Wide Wheat Agree to Collaborate on Wheat


INDIANAPOLIS and PHOENIX - (June 2, 2009) -- Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, and World Wide Wheat (W3) LLC of Phoenix, Ariz., announced today a collaboration agreement for the development and commercialization of advanced germplasm and traits in wheat.

The concept of the collaboration is to couple Dow AgroSciences expertise in Seeds and Traits with W3’s proprietary wheat germplasm and robust breeding capabilities. Dow AgroSciences’ experience in seed and trait commercialization will be leveraged to bring the next generation of wheat to market. W3 brings more than 40 years of plant breeding to the collaboration and will be able to leverage Dow AgroSciences’ reach in key global markets such as North America, Latin America, Europe and Australia.

“We are very pleased to be working with W3, an industry leader in wheat breeding, to launch a portfolio of new products in the near future,” said Jerome Peribere, President and CEO of Dow AgroSciences. “This collaboration will build upon our current seed portfolio by expanding into wheat -- a very important global crop which supplies a significant amount of the daily nutrition in human diets. And, we look forward to utilizing our R&D breeding and trait technologies such as EXZACT™ Precision Technology to bring advancements in productivity and quality to market.”

“We are excited to collaborate with Dow AgroSciences, a significant player in Seeds and Traits,” said Sheldon Richardson, Chairman and CEO of W3. “With Dow AgroSciences as our partner, we can leverage customer relationships within the food chain and their marketing and commercialization expertise. Our four decades of plant breeding experience brings a wide diversity of germplasm offering of high yielding varieties developed for markets around the world.”

About World Wide Wheat (W3)
World Wide Wheat (W3), headquartered in Phoenix, is one of the world’s leading independent plant breeding companies whose research is devoted to the improvement of wheat, barley and oats - major food crops of the world. World Wide Wheat operates research stations in 18 countries, producing superior varieties of cereal grains that are not genetically modified. For more information see www.worldwheat.com.

About Dow AgroSciences
Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element” to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion.  Learn more at www.dowagro.com.

™Trademark of Dow AgroSciences LLC




BIO5 and World Wide Wheat Ink Partnership


Tucson and Phoenix, Arizona -- The University of Arizona's BIO5 Institute and World Wide Wheat, L.L.C., two of Arizona’s leading research groups, announce a partnership to develop foods that will help reduce obesity, diabetes, heart disease, cholesterol levels and cancer. This research partnership will develop new wheat, barley and oat varieties with major health benefits.

This synergistic public/private collaboration combines BIO5’s cutting edge genomics, proteomics and metabolomics bioresearch with World Wide Wheat’s extensive germplasm (plant breeding material), grain collection and expertise in plant breeding to produce superior varieties with properties that produce better tasting, but healthier food with improved nutritional value. The goal of this combined effort is to achieve high quality outcomes that will efficiently and successfully introduce new products to the marketplace that benefit society. One example that will benefit diabetics is a new variety of wheat that will produce flour that doesn’t rapidly increase blood sugar levels, while producing good tasting bread with lower fat content.

“World Wide Wheat is an ideal partner for us, as it shares common goals and brings complimentary expertise”, said Vicki Chandler, Director of BIO5. “This partnership exemplifies BIO5’s mission to translate research findings into real world applications that benefit the public.”

“BIO5 is one of the finest biotech research groups in existence and brings incredible expertise to a partnership destined to be one of Arizona’s most important assets”, said Kirk Kroloff, Executive Vice President of World Wide Wheat.

BIO5 is a collaborative interdisciplinary research institute at the University of Arizona, located in Tucson, which brings together top scientists from five disciplines - agriculture, medicine, pharmacy, engineering and basic science - to solve some of the world’s most important problems. BIO5 creates science, education and industry partnerships to disseminate knowledge and apply the knowledge gained to treat disease, feed humanity and preserve livable environments. For more information see www.bio5.org.

World Wide Wheat, headquartered in Phoenix, is one of the world’s leading independent plant breeding companies whose research is devoted to the improvement of wheat, barley and oats - major food crops of the world. World Wide Wheat operates seventeen (17) research stations in seven (7) different countries, producing superior varieties of cereal grains that are not genetically modified. For more information see www.worldwheat.com.



All Rights Reserved. All logos, trademarks and graphics are property of their respective owners.